Abstract
This study aimed to determine the interrater and intrarater reliability and agreement and the minimal detectable change (MDC) of the Timed Up & Go (TUG) test and the 10-Meter Walk Test (10MWT) in older patients with Chronic Obstructive Pulmonary Disease (COPD). Patients (≥ 60 years old) living in the community were asked to attend 2 sessions with 48–72-hour interval. In session 1, participants completed the TUG and 10MWT twice (2 trials) and were assessed by 2 raters. In session 2, they repeated the tests twice and were assessed by 1 rater. Interrater and intrarater reliability were calculated for the exact scores (using data from trial 1) and mean scores (mean of 2 trials) using Intraclass Correlation Coefficients (ICC2,1 and ICC2,2, respectively). Interrater and intrarater agreement were explored with the Bland & Altman method. The MDC95 was calculated from the standard error of measurement. Sixty participants (72.43 ± 6.90 years old) completed session 1 and 41 participants session 2. Excellent ICC values were found for the TUG test (interrater: ICC2,1 = 0.997 ICC2,2 = 0.999; intrarater: ICC2,1 = 0.921 ICC2,2 = 0.964) and 10MWT (interrater: ICC2,1 = 0.992 ICC2,2 = 0.997; intrarater: ICC2,1 = 0.903 ICC2,2 = 0.946). Good interrater and intrarater agreement was also found for both tests. The MDC95 was 2.68 s and 1.84 s for the TUG and 0.40 m/s and 0.30 m/s for the 10MWT considering the exact and mean scores, respectively. Findings suggest that the TUG test and the 10MWT are reliable and have acceptable measurement error. Therefore, these measures may be used to assess functional balance (TUG) and gait (10MWT) deficits in older patients with COPD.
Highlights
Chronic Obstructive Pulmonary Disease (COPD) is one of the most prevalent chronic diseases among adults aged 60 and older [1] with systemic manifestations that can contribute to functional performance decline [2]
These findings suggest that, when using Timed Up & Go (TUG) scores in COPD, clinicians should calculate the average of 2 measurements in order to reduce the magnitude of measurement error and be more confident that a real statistical change has occurred [36]
Previous studies using the TUG test to evaluate the effects of an intervention in patients with COPD have found preposttest mean differences of -1.5s [44] and -1.7s [17], which are lower than the minimal detectable change (MDC) values found in the present study (2.68s and 1.84s for the exact and mean scores, respectively)
Summary
Chronic Obstructive Pulmonary Disease (COPD) is one of the most prevalent chronic diseases among adults aged 60 and older [1] with systemic manifestations that can contribute to functional performance decline [2]. The TUG test [10] is frequently used to assess functional balance, mobility skills and fall risk of older people [14, 15] and has been increasingly used in patients with COPD [4,5,6,7, 16, 17] It incorporates a series of tasks necessary for independent living, such as walking, turning and sitting [18], providing a comprehensive representation of balance and functional mobility capacities of an individual. Another practical measure to assess functional mobility is the 10MWT [11,12,13].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: COPD: Journal of Chronic Obstructive Pulmonary Disease
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
